In our study of 225 human tumors of different types, the highest prevalence of GLO1 copy number increase was in breast cancer (22%), sarcomas (17%), and non-small cell lung cancer (NSCLC) (11%) [99]. This evidence concerns the gene GLO1 and non-small cell lung carcinoma.